NASDAQ:MACK
Merrimack Pharmaceuticals Stock News
$15.00
-0.0300 (-0.200%)
At Close: May 03, 2024
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
12:00am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO
12:28pm, Friday, 28'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on Feb. 27)
Global Cord Blood Corp (...
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Feb. 26.) Co-Diagnostics Inc (NASDAQ: CODX ) Fat
What Kind Of Share Price Volatility Should You Expect For Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK)?
04:14pm, Friday, 07'th Feb 2020
Anyone researching Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) might want to consider the historical volatility of...
Sepio Capital, LLC Buys Resideo Technologies Inc, iShares —…+ Year Treasury Bond ETF, Funko ...
12:00am, Thursday, 06'th Feb 2020The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves Into Clinics
12:22pm, Thursday, 16'th Jan 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on Jan. 15)
10X Genomics Inc (NASDAQ...
Lantheus Holdings Announces Senior Leadership Appointment
01:30pm, Monday, 13'th Jan 2020
Lantheus Holdings, Inc. (NASDAQ: LNTH) ("Lantheus"), parent company of Lantheus Medical Imaging, Inc. ("LMI"), a leader in the development, manufacture and commercialization of innovative diagnostic i
Hedge Funds Are Selling Merrimack Pharmaceuticals Inc (MACK)
12:44am, Monday, 23'rd Dec 2019
Is Merrimack Pharmaceuticals Inc (NASDAQ:MACK) a good stock to buy right now? We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Dec. 19.) Acceleron Pharma Inc (NASDAQ: XLRN ) Arde
Merrimack Pharmaceuticals Adopts Section 382 Net Operating Loss Rights Plan
02:15pm, Tuesday, 03'rd Dec 2019
Merrimack Pharmaceuticals, Inc. (MACK) (the “Company” or “Merrimack”), announced today that its Board of Directors (the “Board”) has adopted a Section 382 net operating loss rights plan (t